In our previous report, tumor samples from patients with lung adenocarcinoma showed MAFB expression in locations comparable to CD68- and CD204-positive TAMs and were abundant in severe stages of cancer [21]. The gene discussed is CD68; the disease is lung adenocarcinoma.